[EN] PYRAZOLE DERIVATIVES ASR ET KINASE INHIBITORS<br/>[FR] DÉRIVÉS DE PYRAZOLE EN TANT QU'INHIBITEURS DE KINASE RET
申请人:[en]ELI LILLY AND COMPANY
公开号:WO2022098970A1
公开(公告)日:2022-05-12
Disclosed herein are compounds of formula I: or a pharmaceutically acceptable salt thereof, where the variables are as defined herein. These compounds are useful in treating RET associated cancers. Formulations containing the compounds of formula I and methods of making the compounds of formula I are also disclosed.